Advertisement

Topics

Abcam forecasts double digit revenue growth for full-year as it sees product growth across the board

07:59 EDT 12 Jul 2018 | Proactive Investors

The AIM-listed antibody supplier said it expected revenue for the full year to grow by 10.7% in constant currency, with catalogue growth of “over” 10%

Original Article: Abcam forecasts double digit revenue growth for full-year as it sees product growth across the board

NEXT ARTICLE

More From BioPortfolio on "Abcam forecasts double digit revenue growth for full-year as it sees product growth across the board"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...